Esperion Therapeutics
ESPR
#6525
Rank
C$1.14 B
Marketcap
C$4.46
Share price
-0.47%
Change (1 day)
198.89%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.71. In 2024 the company made an earnings per share (EPS) of C-$0.33 an increase over its 2023 EPS that were of C-$3.00.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.71118.28%
2024C-$0.33-89.15%
2023C-$3.00-40.28%
2022C-$5.02-62.87%
2021C-$13.5280.38%
2020C-$7.5050.14%
2019C-$4.99-53.18%
2018C-$10.667.41%
2017C-$9.93110.81%
2016C-$4.7147.35%
2015C-$3.200.89%
2014C-$3.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.85-362.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$60.15-8,606.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.64 1,122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.98-380.00%๐Ÿ‡บ๐Ÿ‡ธ USA